25 May 2013
Keywords: bayer, factor, viii, drug, gets, fda, go-ahead
Article | 20 October 2008
Germany's Bayer HealthCare has received an additional indication from the US Food and Drug Administration for its Kogenate FS antihemophilic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 October 2008
20 October 2008
24 May 2013
© 2013 thepharmaletter.com